A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
Clinical trial NCT00333775 · COMPLETED
Trial details
- NCT number
- NCT00333775
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-10-01
- Enrollment
- 736
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.